All existing studies on ivermectin against Covid with a mortality endpoint now total more than 6,000 patients and show a 78% reduction in deaths.
At the current global fatality rate, this could save 300,000 lives per month.
With an outstanding safety profile.
At a minimal cost. pic.twitter.com/74harMhYNv— Covid19Crusher (@Covid19Crusher) January 17, 2021
